Debiopharm International S.A.
- Biotech or pharma, therapeutic R&D
Debiopharm develops innovative therapies that target high unmet medical needs in oncology and bacterial infections. We are seeking to in-license promising preclinical oncology assets (small molecules, biologics) with solid tumor indications.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}